Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study

Asthma Clinical Trial

Official title:

Cornell Translational Behavioral Science Research Consortium: Asthma Qualitative Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00195065
• Other study ID #: N01-HC-25196 (9811003566)
• Status: Completed
• Phase: N/A
• First received: September 13, 2005
• Last updated: April 1, 2008
• Start date: April 2003
• Est. completion date: September 2003

Study information

• Verified date: April 2008
• Source: Weill Medical College of Cornell University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

To explore and illuminate the cultural, social, and psychological factors that either facilitate or serve as barriers to behavioral change in asthma patients.

Description:

1. Through a series of open-ended questions we will explore and build a better understanding of how different patient populations view asthma and the difficulties they face in changing behavior. In addition the responses to such questions should help us to better understand and anticipate some of the barriers and issues that participants may face in successfully changing their behaviors.

2. The second objective is to use the responses obtained to inform how an intervention of positive affect induction and self-affirmation should be operationalized and tailored.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: September 2003
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Patients will be eligible for this study if their physicians consider them medically able to participate, if they are 18 years of age or older, and if they have a diagnosis of mild to moderate asthma based on the NHLBI Asthma Expert Panel's classification system which rates symptoms, frequency of exacerbations, nocturnal attacks, activity restriction, use of medications, and pulmonary function.

Exclusion Criteria:

Patients will be excluded from this study for the following reasons:

• If they are unable to walk several blocks for whatever reason;

• If they have musculoskeletal or neurological deficits that preclude increased physical activity;

• If they have other pulmonary diseases;

• If they have cardiac disease or other severe comorbidity;

• If they are unable to provide informed consent because of cognitive deficits;

• If they refuse to participate.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Asthma

Intervention

Behavioral:
• Semi-structured, open-ended interviews

Locations

Country	Name	City	State
United States	New York Presbyterian Hospital-Weill Medical College of Cornell University	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Weill Medical College of Cornell University

Country where clinical trial is conducted

United States, 

References & Publications (5)

Mancuso CA, Peterson MG, Charlson ME. Effects of depressive symptoms on health-related quality of life in asthma patients. J Gen Intern Med. 2000 May;15(5):301-10. — View Citation

Mancuso CA, Peterson MG. Different methods to assess quality of life from multiple follow-ups in a longitudinal asthma study. J Clin Epidemiol. 2004 Jan;57(1):45-54. — View Citation

Mancuso CA, Rincon M, McCulloch CE, Charlson ME. Self-efficacy, depressive symptoms, and patients' expectations predict outcomes in asthma. Med Care. 2001 Dec;39(12):1326-38. — View Citation

Mancuso CA, Rincon M, Robbins L, Charlson ME. Patients' expectations of asthma treatment. J Asthma. 2003 Dec;40(8):873-81. — View Citation

Mancuso CA, Sayles W, Robbins L, Phillips EG, Ravenell K, Duffy C, Wenderoth S, Charlson ME. Barriers and facilitators to healthy physical activity in asthma patients. J Asthma. 2006 Mar;43(2):137-43. — View Citation